VIGNOLA MARK J. (Chief Financial Officer) purchased 5.5% of their position (4.79K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $21.3K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/4/2024ACC: 0001562180-24-004665
Officer· Chief Financial Officer
Since Feb 2021
+4.79K
Net shares
Net buyer
$21.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.79K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.79K
Price / share
$4.44
Trade value
$21.27K
% of position
5.5%
5/31/2024
87.15K→91.94K
Total
Net shares
+4.79K
Net value
$21.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/31/2024 | P · Purchase | +4.79K | $4.44 | $21.27K | 5.5% | 87.15K | 91.94K |
| Total | +4.79K | $21.27K | ||||||
Derivative Transactions0
No derivative transactions reported